These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37931255)

  • 1. The Mifepristone Litigation: Untangling the Implications of the Fifth Circuit's Decision for Abortion Access and the U.S. Food and Drug Administration.
    Zettler PJ; Grossman LA; Adashi EY; Cohen IG
    Ann Intern Med; 2023 Dec; 176(12):1666-1669. PubMed ID: 37931255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Court lifts ban on enforcing Miss. anti-abortion law.
    Denniston L
    Sun; 1992 Aug; ():3A. PubMed ID: 12286287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Appeals court finds Utah late abortion restrictions unconstitutional.
    Reprod Freedom News; 1995 Sep; 4(16):2. PubMed ID: 12320245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remote Reproductive Rights.
    Rebouché R
    Am J Law Med; 2022 Jul; 48(2-3):244-255. PubMed ID: 36715252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benten v. Kessler: the RU 486 import case.
    Pine RN
    Law Med Health Care; 1992; 20(3):238-42. PubMed ID: 1434768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Judicial interference with mifepristone.
    Hamburg M; Sharfstein J
    Science; 2023 Apr; 380(6642):223. PubMed ID: 37053463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supreme Court refuses to review clinic access law; Second Appeals Court upholds statute.
    Reprod Freedom News; 1995 Jun; 4(13):2-3. PubMed ID: 12346292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mifepristone REMS: A needless and unlawful barrier to care✰.
    Kaye J; Reeves R; Chaiten L
    Contraception; 2021 Jul; 104(1):12-15. PubMed ID: 33930383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDA preemption of conflicting state drug regulation and the looming battle over abortion medications.
    Grossi P; O'Connor D
    J Law Biosci; 2023; 10(1):lsad005. PubMed ID: 36938304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Supreme Court's Abortion Exceptionalism - Judicial Deference, Medical Science, and Mifepristone Access.
    Fox D; Cole E
    N Engl J Med; 2021 Jun; 384(24):e94. PubMed ID: 33909959
    [No Abstract]   [Full Text] [Related]  

  • 11. Mifepristone Paternalism at the FDA.
    Paradise J
    J Law Med Ethics; 2023; 51(3):554-559. PubMed ID: 38088593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Mifepristone Case and the Legitimacy of the FDA.
    Gluck AR
    JAMA; 2023 Jun; 329(24):2121-2122. PubMed ID: 37266955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hearing on RU486 is held as test case fails to alter FDA's "import ban".
    Wash Memo Alan Guttmacher Inst; 1992 Jul; (12):2-3. PubMed ID: 12344814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "A Vigorous Campaign against Abortion": Views of American Leaders of Eugenics v. Supreme Court Distortions.
    Lombardo PA
    J Law Med Ethics; 2023; 51(3):473-479. PubMed ID: 38088609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of Wyeth v. Levine on FDA regulation of prescription drugs.
    Ausness RC
    Food Drug Law J; 2010; 65(2):247-83, i-ii. PubMed ID: 24475542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mifepristone approval delayed, supporters look to action by FDA.
    Contracept Technol Update; 2000 May; 21(5):53-5. PubMed ID: 12295903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mifepristone: A Safe Method of Medical Abortion and Self-Managed Medical Abortion in the Post-Roe Era.
    Schmidt EO; Katz A; Stein RA
    Am J Ther; 2022 Sep-Oct 01; 29(5):e534-e543. PubMed ID: 35994387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Physician Attack on the FDA - Will the Supreme Court Reduce Access to Mifepristone?
    Watson K
    N Engl J Med; 2024 Feb; 390(6):563-567. PubMed ID: 38265642
    [No Abstract]   [Full Text] [Related]  

  • 19. Science v. Ideology in Court: Mifepristone and the U.S. Food and Drug Administration.
    Mariner WK
    Ann Intern Med; 2023 Jun; 176(6):857-858. PubMed ID: 37068280
    [No Abstract]   [Full Text] [Related]  

  • 20. Exploring the impact of mifepristone's risk evaluation and mitigation strategy (REMS) on the integration of medication abortion into US family medicine primary care clinics✰,✰✰.
    Razon N; Wulf S; Perez C; McNeil S; Maldonado L; Fields AB; Carvajal D; Logan R; Dehlendorf C
    Contraception; 2022 May; 109():19-24. PubMed ID: 35131289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.